Low Dose Naltrexone

A next-generation, non-opioid treatment, LDN is a biphasic pill with immediate shell release that targets inflammation and pain pathways to potentially provide lasting relief without addiction risks.

Highlights

Entering Pivotal Studies with FDA orphan drug designation

Reduces chronic inflammation and potentially rewires pain perception

Completed several clinical trials with strong safety data

How it Works

LDN works through a unique mechanism of action targeting pain and inflammation pathways:

Acts on Toll-Like Receptors (TLR) to modulate pain perception
Increases endorphins, the body's natural painkillers
Reduces microglial cell activity, which plays a role in chronic pain
Decreases interleukin activity, lowering nerve inflammation

Low Dose Naltrexone

Highlights

Entering Pivotal Studies with FDA orphan drug designation

Reduces chronic inflammation and potentially rewires pain perception

Completed several clinical trials with strong safety data

How it Works

Alyea Clear Patch

Company

Solutions

Contact

Newsletter